TDAC
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$10.85
−0.05%Jul 28, 2026, 13:00 UTC
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.
Source:Jul 6, 2026, 13:51 UTC
Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.
Source: